Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianmarco Mastrogiovanni

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Investigation|November 18, 2014
The plastic liver: differentiated cells, stem cells, every cell?Christopher J Hindley, Gianmarco Mastrogiovanni, Meritxell Huch
Oncotarget|March 13, 2015
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiationNadia Casini, Iris Maria Forte, Gianmarco Mastrogiovanni, et al.
Nature Communications|January 18, 2022
RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-stateGermán Belenguer, Gianmarco Mastrogiovanni, Clare Pacini, et al.
BMC Developmental Biology|February 27, 2020
Long-term expansion, genomic stability and in vivo safety of adult human pancreas organoidsNikitas Georgakopoulos, Nicole Prior, Brigitte Angres, et al.
Nature Medicine|November 14, 2017
Human primary liver cancer-derived organoid cultures for disease modeling and drug screeningLaura Broutier, Gianmarco Mastrogiovanni, Monique Ma Verstegen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Investigation|November 18, 2014
The plastic liver: differentiated cells, stem cells, every cell?Christopher J Hindley, Gianmarco Mastrogiovanni, Meritxell Huch
Oncotarget|March 13, 2015
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiationNadia Casini, Iris Maria Forte, Gianmarco Mastrogiovanni, et al.
Nature Communications|January 18, 2022
RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-stateGermán Belenguer, Gianmarco Mastrogiovanni, Clare Pacini, et al.
BMC Developmental Biology|February 27, 2020
Long-term expansion, genomic stability and in vivo safety of adult human pancreas organoidsNikitas Georgakopoulos, Nicole Prior, Brigitte Angres, et al.
Nature Medicine|November 14, 2017
Human primary liver cancer-derived organoid cultures for disease modeling and drug screeningLaura Broutier, Gianmarco Mastrogiovanni, Monique Ma Verstegen, et al.
Pageof 1